Skip to main content
Fig. 5 | BMC Medicine

Fig. 5

From: HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis

Fig. 5

Relapse-free survival in combined TCGA-BRCA and METABRIC dataset. A ERBB2 CNV based on GISTIC definition in the entire cohort. B ERBB2 CNV neutral vs non-neutral (other) status in the entire cohort. C ERBB2 CNV neutral vs non-neutral status in hormone receptor-positive subgroup. D ERBB2 CNV neutral vs non-neutral status in hormone receptor-negative subgroup

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us